What really matters to patients with severe heart failure: tradeoffs between quantity and quality of life  by Aaronson, K.D. et al.
JACC February 1998 305A 
with known premature Cl io is important and may influence subsequent risk 
of early CHD in asymptomattc family members. 
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Cal4NI m I~I~H~ Itmee ~f  b(Nm e~M¢l  (4 m U~td  1 ~ South Afeca), We_ 
au, me¢t Ihe low rate In US t~¢kz i= because ~o e~e hu  ~ leekS. 
we h~v~ =tuele¢1160 ~ ~ by a i~bend u~th ~ ~ 
na~ arle~ athe~o~ ~ (C:AD), U=nO tl~ ~ devefoped I~ me 
MEI~I~D (Make_ Eady ~ l=~sve~ Early ~ )  l~Ogfa~n at the U~v. 
oi Utah we h~ k~ed 1' ~ (¢7%) mat mee! !he c ~  fo~ hFH: TC 
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~. , - ,6  deg~e n~a~.  58% of whom also have hFH. 
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of a cdy Ihat is co~iin ttte wintm- and hol and hun~i m the summec 
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-9~ Ten Year Trends in Cam for Corzgestive Hospital 
Heart Failure: Improved Ou~-omes. Increased 
Procedures and Higher Costs 
C.A. Polanczyk. LE.P. Ro~de. M. Call. T. DiSah~. Massachusetts General 
Hos~mk Bos~,n. MA. USA 
Chaxcj~ o~er ttme in outcomes and resource ubl~.abon m hosptal care ol 
congestive heart failure (CHF) have not been widely sludmd. To examine 
tre~ls of mortality rates, resource utdizatJon and cosls in patients edmittsd to 
an academic medical center, all 6,676 pahents hospitalized with pnman/ICD-9 
drag~:~ses of CHF between 1986 apd 1996 were ~ .  Palfi~nt outcomes 
and resource utilizatton were ~sk-adlUSted for sooo..demog~ic harec- 
tenstics and assooated comod~ties using muffiple regression analyses. A 
yearly, discount rate of 7% was used to convert all costs to 1996 US$. 
Resu/ts (see teb4e): The mean age was 70 + 13 years, 54% were male 
and 8"/% were white. FOr all trends, p value <0.01. Invaswe prooedures = 
cardiac catheterization, PTCA. CABG, IABP, mechamcat ventilation, invas=ve 
hemedynamic monitoring and dialysis. 
Conclus~n: A signifcant decrease in hospital mortality was observed in 
a 10 year period, even after controlling for soc~o-demographic characteristics 
Years 1986--87 1988--89 1990-91 1092-93 1994~96 
(n=942) (n=1126) (n=1302) (n81411) (n=1896) 
ln.h ospital mot  aid'y. % 8.4 8.5 7.1 6.3 6.1 
Ad~sted motla|~tv 9.1 8.8 6.7 5.7 6,4 
Invasive Procedures. % 19 21 24 28 24 
Length of stay. days 9.8 10.7 11.2 10.3 8.8 
Adjusted length of ~ay 10.4 11.0 10.9 9.9 8.9 
Total costs. 1996 US$ 2.814 4.182 7.036 10.760 12.759 
Adjusted total costs 2.800 4.107 6.913 10.579 13.039 
and comort~o'ffle8, These clara indcat~ tt~! the ¢1e¢~ m mortatlly was 
achm'~:l at tho expense of increased proceclum ulihzaho~ and h~gher overall 
hesr~lal costs, 
~ ImlNmt of t tN I th  Imlu~ ~ on Outcome in 
I~kmm With Advon¢~114eort F i I lum Refwr~l  for 
Hur t  Tr lmlp l ln lM!on 
JA. Waldtm, M,A, Haf~lt0n, G,C. FoNifow, MA. Woo, N,A I.~in01!I0~, 
^. Hage, JO, Mortguchi. UCLA MecI~al Ce~. , Lo~Angek~ CA, t/SA 
To ~ me impect ~ I~l lh  msurm~ stature cm (:~mm outcome in acl. 
v~no~i heart fa*lum, w~ ~ 563 ~ who w~re ewJuate0 and ac- 
tep id  for heart tm~Uon (Tx) t~twetm 1~P2 and 1~u9~,/U~ 
were ~ at 6 ~n~m~ of e~mry 2-3 months m t~e heart lai!um oemer, t~t 
no~HMO pt= had g l~m 4¢ce~ tO ~ ¢llm. P ~  were 91 ~ 
ba,~ed on the~¢ Pf~W ~ in~n,n~o (~0emge ~nd ana~ for 
se~ al bn~ of referral, peecenl t~ l l ted ,  sl~tt~s elf time of Tx, ~md sur- 
vival. In em four m~mnce ¢~legoncs, 168 (34%) pt~ ha0 p~vale insurance 
(P), 123 (22%) heel managed ¢~m p~na (HMO), 148 (26%) ha~ Me¢ltcam 
(MCR), and t 04 (18%) had MedcaKI (MCD). ~ 4 gmupe had =lr~lar 
of illness ~ at ~ 0! mfewal (mean @ 52 y~. NYHA 3.5, LVEF 24). 
W~th average f/u of 19 mont~, no differences were ~m~ m fotal modal~. 
Howevm. a g~er  pmpe~ of HMO pte mqu~md u~0e~ 1'I (20%), corn- 
pined Io P, MCR, and MCD (15%, 1~,  19% p < 0.0C01, p = 0.02, p = 0.18) 
~d~on~dly, fe~,~r HMO I~ were able to avord Tx (44%), compam~ fo P and 
MCD (5~%, 61% p = 0.04, p = 0.02). 
Cm~m~- Anlx~gh ove~a~ mmmml was em~ar aoo~ all mmmmce 
groups, pa'dents ~,ec l  uncl~ ~ cam p~s requ,ed urgem I~m 
van,~plammion morn f~lU~-d~y and we,e le~ ~ely to ave~l Iran~l~mm~on 
~ access to a heart fm]um spacmMy center may help to ~ 
c~,.ca~ mb~y an~ anow pa~e~s to dete~ Wansp~anta~o~ v hout adveme~/ 
e ~  surwval. 
~ ldemli~in 9 Patients Risk for Recurrent at Hospnal 
Admission for Heart Failure 
EF ~ J.B. I:kerde~. Het~/FottYHo~i~a/. C~hu~L Aft& 
Hea~lca~e. Coc~,stown. N~, USA 
Back~R:~Jncf: ReoJrrent hes~ admm~on~ for HF are &arrmngly common; 
the pred~cto~ of ma~.=.on am not well Imown. 
Me,J~oo~: ~ me New yo~ sta~e,.~ ; -~ ia l  data set we compared Ihe 
foflowmo ~ 9.112 patm~ts ~ only 1 HF acb~s~io~ and 33,619 w~h 
>1 d~ 1095: Oemographf¢~.  illness. ~ta l  lyt'l~O(~l~ L~ 
processes of care. A simple readn~ss~on Risk Score was denved by count- 
iP.g Itte nomi0~r of pO~lhVe ~Om pre~ant ~ ~ =lumber o1' rNi~al~ve 
predmtora 
Result- Rez~l~ls$,on was independ~ntty related to black race, Medicaid 
a~d MedCam msuranoe, ~;~,,~.,1 ~=p~al, ~eme~ monit~ng, disc~r~ 
against a<Ntce, and these comorbKM~s: i~:~remic end ~,alvular head cl~- 
ease. ~,,~.athic arcbo~/opall~/, d~ie-~, renal disease, COPD, pdor heart 
surgmy, b e ~  vascular disease and anemsa. Dmchefge to a numtng 
home. cardmc cath and ~ were related to lower risk. Shawn 
rs the incremental relabonsh~p between Rink Score and readmts~o~ rate: 
Score Rate Sco~ P~le S¢om Ram 
3 to 0 0 6% 3 20.0'% 6 29.7%, 
t 13.6% 4 23.1~0 7 34~,~ 
2 166% 5 263"='= ,8 400% 
ConcYus~o~s: 1) Using a large, co.-nl~rehensNe data set not restrcted by 
insurance payor, we identified ~gnificam i~'eo~¢to rs of recurrent 8o~l'fisston for 
HF: 2) our simple Risk Score m~ght De used to )dentlty candidates for care 
management to reduce readmissions 
~ W a a t  Matters to Patients With Severe Heart Really 
Failure: Tradeoffs Between Quantity and Quality 
of Life 
K.D. Aaronson. J HoaShi, J. Bowers. T.-M. Chen. UnwerstlyofM~htgan 
Medical Center, Ann Arbor. ML USA 
Backgn:~-~: Although development and approval of drugs for CHF is largely 
focused on improving sunlival, a drug's impact on quantity of life may differ 
from its effect on quality of life (QOL). How patients (pts) with severe CHF 
value quantity vs. QOL is unknown. 
Methods: We assessed the willingness of outpatients with chronic NYHA 
class Ill (n = 44) or IV (n = 3) CHF to accept decreased (~uant~ty to obtain im- 
proved QOL QOL was assessed with the Living with Heart Failure Question- 
naire (LHFQ). Utility for CHF-related QOL w~s assessed ~' st=_ndard gamble 
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(relief of all CHF symptoms and limitations [but no change in survival] vs, 
varying risk of Immediate painless death), Willingness to accept a 10 point 
improved LHFQ for varying decrements of a hypothetical 36 monlh life ex- 
poctancy was assessed in a series el time tradooffs; a second eat o! trodoelfs 
was made agl~tnst ~t's solf-o~tlmated prognosi~l (SEPt. 
Results: Mo~t pts wore relatively unwilling to gamble Immediate death 
for resolution o! CHF symptoms (modton [~eoptnblo rl,k of death ~, 5%) or 
to trade month8 of lifo for Improved QOL (median tradooff 1 of 36 montht~ 
nnd 3,5% of SEPt, However, 25% of pts would give tip -,6 out el 36 months 
for n 10,polnt Improvement in LHFQ; 25% of DiS would give up -15% of 
their SEP lot the sr~me t0 point LHFQ Improvement; ned 25% et pt~ were 
willing to ~eopt ::30".',. rlt~k of immediate doeth for complete re~nlul~on of 
their symptom~ of henri l~lltlm, Pntlont~ with the wo~,t CEP .~do the largest 
tr~d~Olfll ( ]po~lrmnn'~ R =~, 0,207, P ,. 0.084) nnd gambles (Spenrmrln'e R = 
,0,373, P = 0,013), LHFQ s(:om was not ~tl.qoclntod with wtlllngne~ to trade 
or gamble, 
Cenclusien~: A ~ubstnntlnl minority of ptt~ with advanced CHF I~lghly value 
QOL end would proler ~1 shorter Ilia with improved qilnltty, CHF p~tionts' 
~tO~,tls hould be ~d(tr~ssed b~( tltel~ ~h~s(c(P,n~,, and ~beuld be mflo(~ted 
the d/~t devai~4~man# nnd nppmva/ pmcaa, e
1132-~] Care Mensgara Versus Carepaths: An Active 
Approa©h to Care Manegement Reduces Coat and 
Length of Stay In Patients With Congestive Heart 
Failure 
0 Col~tantlnl, E. S~teldlev, K Huek, K,K. Doyd, L~,S. Coepol, MD OallSOn 
Univ~r~@ HO;~ptta/s of C/~t~ncI.C~n We,*h~m Rt~erve Unit~rsift', 
ClovPland, OH, USA 
~lckgro~ncl', Clinical c~mp,~tl~ to enhance quality nnd decre~l~o l~asplt~ll 
~'~li~ls h~lve h,~¢l ow ulilitatlon, We hypothesized lhaI an active approt~ch 
would optimize adherence In a clinical oaropath o,'tlitblisl~ed for congestive 
heart latium (CHF) at our tnstihllien In 19913 
Methed~: In the ~o¢ond quarter el 1997, a CHF inanagemont eam con- 
st~ttng of a nurse care mnn~iger and ,~ facility cardiologist screened patients 
admitted with the dtP, gnosls el CHF and followed them dally, Based on pub- 
lished guidelines, meommend~tlons for diagnostic tests and therapies WOre 
offered d~tlv, both verbally (rod in the chart, to the cltnicinns, The patients who 
worn not screened, but coded !or CHF at discharge, constituted the non-cnre- 
m~nagod group, Length of stay (LOS), variable direct costs (VDC), intensive 
cam unit LOS and tlttrty day readmission rotes wore compared for the two 
groups, 
Resldt~: Ago, inortnlity, and thirty day roadmisston r~tos were not different 
between the two ¢lroups. LOS was shorter lot the caromanagod group (n 
= 97) th~n for the nen-caromanngoff, group (n = 74) (3.7 t 2.3 vs. 56 
4.6days)(p. 0.002), VDCIcaso was lower in the caremanaged group than in 
the non-caromnnagod group ($1199 t 1~31 vs. $2277 i 28131(p . 0,003) 
The intensive care unit LOS was shader in the cmomanagod group than in 
tho non- carereanaged one (0,7 t 1,7 vs. 1,9 t 3,2 days)(p. 0,02). 
Conclusion: The use at a cam management eam approach results in a 
significant redtiction in length el stay and cost for patients with head lailure 
~ Population Baaed Impact of a Heart Failure Care 
Model Designed to Reduce Medical Resource 
Utilization In a Managed Care Environment 
M,R, Mohra, H,O. Venture, F.W Stood, M, Poncho, R.V. Milani, J. Newman, 
D.D, Stapleton, J.P. Murgo, Ochsner Medical Institutions, New Orleans, 
LouiS~nt~l, USA 
Background: The heart failure tHF) conundlum of repeated hospitalizations, 
emergency room (ER) visits, and crisis intervention can benefit by the im- 
plementation of multidisciplinary outpatient care. While the impact el such 
an intervention on selected patients is appreciated, no prewous investiga- 
tion has sought to develop and investigate the effectiveness of a heart failure 
care process model designed for effect upon a large managed care popula- 
tion. 
Methods: We studied the impact of implementation of a heart failure care 
model on an evolving cohort of capitated medicare risk population enrollees 
(age • 65 yrs, n = 19,401 ) by selecting and targeting those heart failure cases 
that consumed the majority el the medical resources. Prospective cdteria for 
reeru,tment included -2 HF hospitalizations in the previous 12 months or one 
HF t'ospitali:'ation that exceeded 2 SDs ~,1 the median length of stay (LOS) or 
cost of care. The cases of heart failure that met this criteria (n = 210, 1.1% of 
the at ask population) were identified and followed in a program of multidisci- 
plinar~ outpatient intervention consisting of intensive education, compliance 
assessment, clinical evaluation, triggered home health care, streamlined ER 
intervention, and outpatient inotropic therapy. The impact on the entire popu- 
lation was assessed by comparing hospitalization admission rates, LOS, ER 
admits, and home health utilization in the 12 months 9rior to 9roaja.m i.~.i.~a.t~ 
(Juno 1995,-May 1996; n = 16,360) to the 12 months of program implementa- 
tion (Juno lg96.-Moy 1997; n = 19,401). 
Results: All rates are expressed as per tO00onrofled members 
Group HF Adlill] LOS (dilys) ER Admil~ Heave Ho~llh 
Baseline year t e,4 55, t 0,6 3 i~ 
Inl~w(tnli(~l Vii(If 14 fi' 46 O" 77' ~ I~' 
% mdilelion tO0 149 ~19.e -31 3 
"p - 0 05 "p = 003 "p = 004= LOS = I.ngth ot ~,tlly 
The program rosulted in 31 fewer HF hospitalizations, t44 tower inl~tion! 
HF days, 33 lass ER HF admits, and 16 fewer homo hofdlh vlsito, which ~a,v~l 
$145,739, No difforoncos in inpatient morh1!ily were noted: 
¢oncll, tslon7 Signili(,'~mt population.wide medical resource ulilit~llion re- 
duction nnd ~osl snvings e~n be m~lized by dove!oping ~ conlprehensivo 
begirt It~ilum c~re process tfltgeting Ilia ¢en~entrated manifest heart failure 
e~lees thrlt ,~onsumo the maioety of the medico! leseumos Imm within a de. 
lined managed c~m population. 
<.,an, o<. - .e . ,a ,<o,  o<.o.ee , . . .< , .  0 .  
. . . . . . . .  lrea©rlblnl el Medications In Patients With Lelt 
ientrlcular Oysfunctlon 
C R. Lacy, JA  Bmone, DM Moylan, M. Btieno, D Sub, JB.  Kostls. 
UMDNJ.RoL~rt i '~ ' l  Johnson Medical School New Oruosw~lc NJ USA: 
Robert Wood Johnson Unwemtty, Hospital New Bnmsw~"k, NJ. US~I 
E~ckgroemd. Clinical ieseaich studios vanably report teat results in trams o! 
differences in relative ask, absolute .sk, rsimbor el patients neo~..¢l to be 
tm~tod tO prevent one event, and other im'~mmotors el clinical o11=oacy. This 
slimy ovaluMe~ response9 e'l heallh cam prolessionals in ~denllcal data |ram 
one clinical mat when presented in dilteronl ways, and moasllred the, hk offhand 
of pmscllbing medication l~sod on interpretation el results. 
Methods: The s~mo results el the SOLVD clinical t.al were presented us- 
ing throe descriptions as it three different drags wore shKlied in three separate 
teals: relative reduction in mortality (%); absolute reduction in mo~tatiy (%1; 
and number el patients needed to be treated to avoid one death. After n.~tow- 
ing study results, 105 physicians and pharmacists estin'klted how likel ~, they 
would be to proscnbe each drug based on a 7 point Likert scale (1 = detmltety 
not prosenbo; 7 = delinitoly prescnbe). 
Results: Likulihood el treatment was statistically significantly highe~ it ...tudy 
results wore presented as relative reduction in mortality compared wtti~ abso- 
lute reduction in mortality or number el patients neoOed to be treated In avail 
one death IP - 0.001). 
Concluston: Methods of reporting trial results signlhcamly affect Inteiplela- 
lions el chnical data by healtlt care professionals and may mlluence present>- 
~ng behawor 
E ~  Do Patients With Heart Failure Experience Better 
- -  Outcomes at Urban Teaching Hospitals? 
E.F. Philbin, T.G. DiSalvo. Henry Forcl Hosl~tal. Detroit. MI. USA: 
Massachusetts General Hospital, Boston MA. USA 
Background: Health cam deliveTy systems influence outcomes m HF; it th~s ~s 
true of hospital type and location is not well known. 
Methods: We utilized the New York statewide hospital data set to identity al 
first HF discharges for the year 1995. Demographics, procedure use, lengtl- 
el stay (LOS), charges, mortality and readmission were compared among 
patilmts at urban teaching (UT, N = 23,071), urban non-teaching (UNT, N = 
8,202), rural teaching RT, N = 672) and rural non-teaching (RNT, N = 3,949) 
hospitals. 
Results: UT patients were more often black, young and hypertensive with 
less comorbid disease (p. 005). Management at UT centers involved more 
procedures and cardiologists, fewer ICU stays, and higher complication rate:; 
(p - 0,05). Clinical outcomes, adjusted tar demographic differences, are 
shown (" = p- 0.05): 
Outcome UT UNT RT RNT 
LOS, d~ws" 9.7 95 7 7 B G 
Charge:,. ,¢'" 13 6"3 10,101 7499 6.677 
Mortahty. °o" 7 3 69 50 5 O 
eadmission % 27.1 265 26 0 258 
Conclusions: 1) HF inpatients treated at UT centers undergo more proce- 
dures and have longer LOS, thus incurring higher hospital charges, without 
fewer roadmissions, 2) adjusted inpatient mortality is highest at UT hospi- 
tals, and, 3) whether these substantial mortality differences reflect disease 
